Armistice Capital’s AYTU BioPharma AYTU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-57,597
Closed -$69.1K 209
2025
Q1
$69.1K Sell
57,597
-92,403
-62% -$134K ﹤0.01% 208
2024
Q4
$255K Sell
150,000
-86,000
-36% -$157K ﹤0.01% 190
2024
Q3
$555K Sell
236,000
-16,000
-6% -$41.4K 0.01% 188
2024
Q2
$736K Buy
+252,000
New +$761K 0.01% 167
2022
Q2
Sell
-118,997
Closed -$2.57M 181
2022
Q1
$2.57M Buy
+118,997
New +$2.96M 0.05% 95
2021
Q3
Sell
-67,119
Closed -$6.72M 138
2021
Q2
$6.72M Hold
67,119
0.12% 92
2021
Q1
$10.2M Buy
67,119
+452
+0.7% +$71.8K 0.23% 76
2020
Q4
$7.97M Buy
+66,667
New +$12.1M 0.27% 72
2020
Q1
Sell
-39,750
Closed -$7.73M 81
2019
Q4
$7.73M Buy
39,750
+14,150
+55% +$2.72M 0.45% 55
2019
Q3
$6.2M Buy
25,600
+15,600
+156% +$4.7M 0.41% 50
2019
Q2
$3.78M Hold
10,000
0.24% 51
2019
Q1
$3.34M Buy
10,000
+9,500
+1,900% +$2.37M 0.18% 60
2018
Q4
$79K Buy
+500
New +$110K 0.01% 69
2018
Q2
Sell
-375
Closed -$956K 77
2018
Q1
$956K Buy
375
+283
+308% +$1.95M 0.07% 61
2017
Q4
$818K Buy
+92
New +$1.1M 0.08% 63

Other funds holding AYTU